| Title | The Effect of Imatinib on Cytomegalovirus Reactivation in Hematopoietic Cell Transplantation. | | Author(s) | Travi G, Pergam SA, Xie H, Carpenter P, Kiem HP, Corey L, Boeckh MJ | | Institution | Fred Hutchinson Cancer Research Center, Seattle, Washington; and 2San Raffaele Scientific Institute, Milan, Italy. | | Source | Clin Infect Dis 2009 Nov 3. | | Abstract | In vitro studies have shown possible antiviral effects of tyrosine kinase inhibitors. In a retrospective study, we show that use of the tyrosine kinase inhibitor imatinib does not appear to reduce cytomegalovirus reactivation during the first 100 days after transplantation in a cohort of hematopoietic cell transplant recipients. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 19886798 |
|
